Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 6.05 CAD 3.6%
Market Cap: 216.9m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of EPRX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EPRX Intrinsic Value
Not Available
Base Case Scenario
Compare EPRX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EPRX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Eupraxia Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eupraxia Pharmaceuticals Inc

Current Assets 28.6m
Cash & Short-Term Investments 27.5m
Receivables 238.5k
Other Current Assets 913.3k
Non-Current Assets 626.8k
PP&E 546.5k
Other Non-Current Assets 80.3k
Efficiency

Free Cash Flow Analysis
Eupraxia Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eupraxia Pharmaceuticals Inc

Revenue
0 CAD
Operating Expenses
-25.9m CAD
Operating Income
-25.9m CAD
Other Expenses
-364.2k CAD
Net Income
-26.2m CAD
Fundamental Scores

EPRX Profitability Score
Profitability Due Diligence

Eupraxia Pharmaceuticals Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

47/100
Profitability
Score

Eupraxia Pharmaceuticals Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

EPRX Solvency Score
Solvency Due Diligence

Eupraxia Pharmaceuticals Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

Eupraxia Pharmaceuticals Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EPRX Price Targets Summary
Eupraxia Pharmaceuticals Inc

Wall Street analysts forecast EPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPRX is 11.22 CAD with a low forecast of 9.09 CAD and a high forecast of 12.6 CAD.

Lowest
Price Target
9.09 CAD
50% Upside
Average
Price Target
11.22 CAD
85% Upside
Highest
Price Target
12.6 CAD
108% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Eupraxia Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EPRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y